University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Development and validation of prognostic survival models in newly diagnosed Parkinson’s disease

dc.contributor.authorMacleod, Angus D
dc.contributor.authorDalen, Ingvild
dc.contributor.authorTysnes, Ole-Bjørn
dc.contributor.authorLarsen, Jan Petter
dc.contributor.authorCounsell, Carl E
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2018-02-01T14:28:07Z
dc.date.available2018-02-01T14:28:07Z
dc.date.issued2018-01-31
dc.descriptionAcknowledgments We would like to thank study participants, study personnel, and study funders. Funding agencies: The Parkinsonism Incidence in North-East Scotland (PINE) study was supported by Parkinson's UK (Grants G-0502, G-0914, G-1302), the Scottish Chief Scientist Office (CAF 12/05), the British Medical Association (BMA) Doris Hillier award, RS Macdonald Trust, the Bupa Foundation, National Health Service (NHS) Grampian endowments, NHS R&D, and SPRING. The ParkWest study was supported by the Research Council of Norway (Grant 177966), the Western Norway Regional Health Authority (Grants 911218 and 911949), and the Norwegian Parkinson's Disease Association.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent636524
dc.identifier107331495
dc.identifierbeff90f6-ee3c-45be-9244-78e9bb6235c8
dc.identifier28976022
dc.identifier28976022
dc.identifier85040677583
dc.identifier.citationMacleod, A D, Dalen, I, Tysnes, O-B, Larsen, J P & Counsell, C E 2018, 'Development and validation of prognostic survival models in newly diagnosed Parkinson’s disease', Movement Disorders, vol. 33, no. 1, pp. 108-116. https://doi.org/10.1002/mds.27177en
dc.identifier.doi10.1002/mds.27177
dc.identifier.iss1en
dc.identifier.issn0885-3185
dc.identifier.otherORCID: /0000-0001-6622-7839/work/164505583
dc.identifier.otherORCID: /0000-0002-6284-4239/work/191926805
dc.identifier.urihttp://hdl.handle.net/2164/9977
dc.identifier.vol33en
dc.language.isoeng
dc.relation.ispartofMovement Disordersen
dc.subjectdependencyen
dc.subjectParkinson's diseaseen
dc.subjectprognosisen
dc.subjectmortalityen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subjectParkinson's UKen
dc.subjectG-0502en
dc.subjectG-0914en
dc.subjectG-1302en
dc.subjectChief Scientist Office (CSO)en
dc.subjectCAF 12/05en
dc.subjectSupplementary Dataen
dc.subject.lccRC0321en
dc.titleDevelopment and validation of prognostic survival models in newly diagnosed Parkinson’s diseaseen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Macleod_et_al_2018_Movement_Disorders.pdf
Size:
621.61 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: